Regulation of the IL-10 production by human T cells

Scand J Immunol. 2001 Feb;53(2):139-47. doi: 10.1046/j.1365-3083.2001.00851.x.

Abstract

Interleukin (IL)-10, an immunomodulatory cytokine predominantly produced by monocytes/macrophages and T cells, inhibits several functions of dendritic cells (DC), monocytes and T cells including their cytokine production, but it stimulates B cell immunoglobulin (Ig) production and cytotoxic T lymphocyte (CTL) generation. A precise knowledge of the mechanisms that control the IL-10 production is therefore highly important for understanding the immunoregulation. The IL-10 production was studied in cultures of freshly isolated human T cells. A rise in intracellular calcium as well as the common gamma-chain containing cytokine receptor triggering or CD28 triggering were found to be important signals for IL-10 induction. CD80, CD58, rIL-12 and rIFN-alpha all had efficacious and independent costimulatory activities on the IL-10 production, while PGE2 was inhibitory. Dependence on autocrine IL-2 signalling was shown by the effects of anti-IL-2 and anti-IL-2R monoclonal antibodies (MoAb), but the IL-10 production proceeded partly IL-2-independent when CD80 provided costimulation. Sensitivity to inhibition by CsA was not removed by CD80 or CD58 costimulation and/or by addition of rIL-12 or rIFN-alpha, pointing to the absolute requirement for calcineurin activity. These data reveal important differences in the regulatory pathways between IL-10 (a cytokine-inhibitory interleukin) and IL-2 (a cytokine-inducing interleukin), which can potentially be exploited therapeutically. The fact that CsA blocks the production of IL-10, which itself has important immunosuppressive properties, should be taken into account in defining immunosuppressive treatment schedules which include the use of CsA.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / immunology
  • Antibodies, Monoclonal / pharmacology
  • B7-1 Antigen / physiology
  • CD4-Positive T-Lymphocytes / drug effects
  • CD4-Positive T-Lymphocytes / metabolism*
  • CD58 Antigens / physiology
  • Calcineurin / physiology
  • Calcium Signaling
  • Cells, Cultured / drug effects
  • Cyclic AMP-Dependent Protein Kinases / metabolism
  • Cyclosporine / pharmacology
  • DNA-Binding Proteins / metabolism
  • Dinoprostone / pharmacology
  • Gene Expression Regulation* / drug effects
  • Humans
  • Immunosuppressive Agents / pharmacology
  • Interferon Type I / pharmacology
  • Interleukin-10 / biosynthesis*
  • Interleukin-10 / genetics
  • Interleukin-12 / antagonists & inhibitors
  • Interleukin-12 / biosynthesis
  • Interleukin-12 / genetics
  • Interleukin-12 / immunology
  • Interleukin-12 / pharmacology
  • Interleukin-2 / antagonists & inhibitors
  • Interleukin-2 / immunology
  • Interleukin-2 / pharmacology
  • Ionomycin / pharmacology
  • Ionophores / pharmacology
  • Leukocyte Common Antigens / analysis
  • Lymphocyte Activation / drug effects
  • NFATC Transcription Factors
  • Nuclear Proteins*
  • Protein Kinase C / metabolism
  • Recombinant Proteins / pharmacology
  • T-Lymphocyte Subsets / drug effects
  • T-Lymphocyte Subsets / metabolism
  • Tetradecanoylphorbol Acetate / pharmacology
  • Transcription Factors / metabolism

Substances

  • Antibodies, Monoclonal
  • B7-1 Antigen
  • CD58 Antigens
  • DNA-Binding Proteins
  • Immunosuppressive Agents
  • Interferon Type I
  • Interleukin-2
  • Ionophores
  • NFATC Transcription Factors
  • Nuclear Proteins
  • Recombinant Proteins
  • Transcription Factors
  • Interleukin-10
  • Interleukin-12
  • Ionomycin
  • Cyclosporine
  • Cyclic AMP-Dependent Protein Kinases
  • Protein Kinase C
  • Calcineurin
  • Leukocyte Common Antigens
  • Dinoprostone
  • Tetradecanoylphorbol Acetate